DCMA Details Oversight of Counterfeit Electronic Parts
Client Alert | less than 1 min read | 08.04.15
On July 6, 2015, DCMA issued Instruction 1205 that provides the framework the government will use to assess compliance with DFARS 252.246-7007 (May 2014), which requires certain contractors to design and deploy systems to avoid and detect counterfeit electronic parts. The instruction assigns roles and responsibilities for DCMA functions, establishes a risk-based approach that will drive the types of oversight and surveillance contractors can generally expect, and details the reporting that may occur if counterfeit materials or suspected counterfeit materials are identified.
Contacts
Insights
Client Alert | 6 min read | 05.12.26
EU Pharma Package: Advertising Compromise Proposal
In our ninth alert in this EU Pharma Package Series, we discussed the proposals of the Commission, Council, and Parliament with respect to advertising of medicinal products.
Client Alert | 6 min read | 05.11.26
FDA’s AI in Early Phase Clinical Trials RFI: An Opportunity to Help Set the Rules of the Road
Client Alert | 4 min read | 05.11.26
New Temporary State Aid Framework Throws A Lifeline To Sectors Hit By The Middle East Crisis
Client Alert | 4 min read | 05.11.26
